Taken together, our findings indicate that dasatinib accelerates VPA-induced AML cell death through G1 arrest and caspase-dependent apoptosis via MEK/ERK and p38 MAPK (Fig. 7). Here, MAP2K7 is linked to acute myeloid leukemia.